Amoxicillin and clavulanate potassium.
To protect amoxicillin from inactivation by beta-lactamases.
Amoxicillin inhibits peptidoglycan synthesis, weakening bacterial cell walls.
Tablets and injections (intravenous or intramuscular).
Intramuscular, subcutaneous, or intravenous injection/infusion.
Reconstituted solution stored at 5°C, used promptly after reaching room temperature.
One 1.2 g vial intravenously every 6-8 hours for severe infections, not exceeding 10 days or 800 mg of clavulanic acid daily.
Diarrhea, nausea, skin rashes, urticaria, abdominal discomfort, flatulence, headache.
History of penicillin allergy, cholestatic jaundice, or hepatic dysfunction related to Hancotin.
Use with caution in patients with hepatic or renal impairment.
Dissolve in 10 mL of water for injections, use within 20 minutes.
Below 30°C, protected from light.
No, mixing can inactivate aminoglycosides.
Manufacturer: Reyoung Pharmaceutical Co., Ltd. (China), Distributor: Anhet Pharmaceuticals LTD (Nigeria).